Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo I Chaia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Receptors & Clinical Investigation|January 15, 2026
Targeting sympathetic glia for treating cardiovascular diseasesAlison Xiaoqiao Xie, Angelo I Chaia, Ken D McCarthy
International Clinical Psychopharmacology|February 28, 2026
Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects?Jamie A Parkerson, Angelo I Chaia, Sean T Lynch, et al.
Schizophrenia Research|March 24, 2026
Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorderSean T Lynch, Kathryn Brooke Renard, Angelo I Chaia, et al.
Journal of Psychiatric Research|April 30, 2026
Beyond medication choice: Predictors of psychiatric readmission after inpatient initiation of long-acting injectable antipsychoticsSean T Lynch, Angelo I Chaia, Kathryn Brooke Renard, et al.
Journal of Child and Adolescent Psychopharmacology|June 9, 2026
Context Matters: Variation in Pharmacologic Management of Pediatric Agitation Across Emergency and Inpatient Psychiatric SettingsSean T Lynch, Angelo I Chaia, Ricky Burns, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19Byron Avihai, Erin P Sundel, Eileen Lee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Receptors & Clinical Investigation|January 15, 2026
Targeting sympathetic glia for treating cardiovascular diseasesAlison Xiaoqiao Xie, Angelo I Chaia, Ken D McCarthy
International Clinical Psychopharmacology|February 28, 2026
Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects?Jamie A Parkerson, Angelo I Chaia, Sean T Lynch, et al.
Schizophrenia Research|March 24, 2026
Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorderSean T Lynch, Kathryn Brooke Renard, Angelo I Chaia, et al.
Journal of Psychiatric Research|April 30, 2026
Beyond medication choice: Predictors of psychiatric readmission after inpatient initiation of long-acting injectable antipsychoticsSean T Lynch, Angelo I Chaia, Kathryn Brooke Renard, et al.
Journal of Child and Adolescent Psychopharmacology|June 9, 2026
Context Matters: Variation in Pharmacologic Management of Pediatric Agitation Across Emergency and Inpatient Psychiatric SettingsSean T Lynch, Angelo I Chaia, Ricky Burns, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19Byron Avihai, Erin P Sundel, Eileen Lee, et al.
Pageof 1